Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $39.87M.
ENTERPRISE VALUE (EV)
$39.87M
Boundless Bio, Inc.
Market Cap
$57.74M
Enterprise Value (EV)
$39.87M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Boundless Bio, Inc. (BOLD) | $57.74M | $39.87M |
| OKYO Pharma Limited (OKYO)vs › | $56.98M | $42.38M |
| Fractyl Health, Inc. (GUTS)vs › | $58.57M | $72.16M |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.79M | $49.98M |
| PDS Biotechnology Corporation (PDSB)vs › | $59.30M | $58.07M |
| Oncolytics Biotech Inc. (ONCY)vs › | $59.66M | $56.00M |
| Adicet Bio, Inc. (ACET)vs › | $60.71M | $40.44M |
| Connect Biopharma Holdings Limited (CNTB)vs › | $60.99M | $34.57M |
| Aldeyra The (ALDX)vs › | $53.98M | $9.03M |
| Spectral AI, Inc. (MDAI)vs › | $53.76M | $56.04M |
Market Cap
$57.74M
Total Debt
$0.00
Cash
$17.87M
Enterprise Value
$39.87M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
